Type 2 Diabetes Mellitus Forecast at 22 Major Markets 2018-2028 – Research and Markets

Wednesday, 13 December 2017 07:06

Type 2 Diabetes Mellitus Forecast at 22 Big Markets 2018-2028 – Research and Markets

This report provides the present prevalent population for type 2 diabetes mellitus across 22 Major Markets (USA, Canada, France, Germany, Italy, Spain, UK, Poland, Netherlands, Norway, Sweden, Denmark, Russia, Turkey, Japan, China, South Korea, India, Australia, Brazil, Mexico, Argentina) split by sex and 5-year era cohort. Along with the prevalence, the report contains a disease overview of these risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Supplying a value-added degree of insight in several of co-morbidities and the symptoms of type 2 diabetes mellitus, some individual parameters and features, in addition to the analysis group have been quantified and presented alongside the total figures. These sub-populations within the disease are contained in a country level across the 10-year prediction photo.

Main symptoms and co-morbidities for type 2 diabetes mellitus include:

  • Chronic kidney disease (CKD)
  • Myocardial infarction (MI)
  • Stroke
  • Lower limb ulcerations & amputations
  • Retinopathy
  • Glaucoma
  • Macular oedema
  • Dementia
  • Gout
  • Chronic heart failure (CHF)
  • Neuropathic pain
  • Peripheral neuropathy

Key Issues Covered:

  1. Introduction
  2. Cause of the Disease
  3. Risk Factors & Prevention
  4. Identification of the Infection
  5. Variation by Geography/Ethnicity
  6. Infection Prognosis & Clinical Course
  7. Crucial Comorbid Conditions / Characteristics Associated With the Disease
  8. Methodology for Quantification of Patient Numbers
  9. Top-Line Prevalence for Type 2 Diabetes Mellitus
  10. Characteristics of Type 2 Diabetes Mellitus Patients
  11. Diagnosis and Treatment Status
  12. Clinical Parameters
  13. Comorbidities of Type 2 Diabetes Mellitus Patients
  14. Lower Limb Ulcerations
  15. Ophthalmic Conditions
  16. Neuropathy
  17. Nephropathy
  18. Macrovascular Diseases
  19. Additional Comorbid Conditions
  20. Abbreviations Used in the Report
  21. Additional Services & Solutions
  22. Reports & Publications
  23. Online Epidemiology Databases
  24. Online Pharmaceutical Pricing Database
  25. References
  26. Appendix

Source: Research and Markets

BiomedReports is not paid or paid from newswires to disseminate or report information and developments about publicly traded firms, but can from time to time receive compensation for advertising, data, analytics and investor relation services from several entities and firms. Full disclosures should be read in the ‘Around Us Section’.

Add this page to a Social Bookmarking sites

Add Comment